Human Immunodeficiency Virus-Associated Nephropathy: A Case Assessment

Kidney disease and highly active antiretroviral therapy (HAART) are associated with and have important roles in the management of human immunodeficiency virus-associated nephropathy (HIVAN). HIVAN can progress to deadly end-stage kidney disease. Current recommendations for HIVAN treatments are largely based on observational data and uncontrolled trials. Potential beneficial treatments include HAART, angiotensin-converting enzyme inhibitors, corticosteroid, dialysis, and renal transplant. Nurse practitioners play important roles in caring for patients with HIVAN.